ClearPoint Neuro Past Earnings Performance
Past criteria checks 0/6
ClearPoint Neuro's earnings have been declining at an average annual rate of -32%, while the Medical Equipment industry saw earnings growing at 13.4% annually. Revenues have been growing at an average rate of 21% per year.
Key information
-32.0%
Earnings growth rate
-15.0%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | 21.0% |
Return on equity | -104.3% |
Net Margin | -92.2% |
Next Earnings Update | 07 May 2024 |
Recent past performance updates
Recent updates
ClearPoint Neuro: Macro-Induced Multiple Compression
Apr 25Are ClearPoint Neuro, Inc. (NASDAQ:CLPT) Investors Paying Above The Intrinsic Value?
Apr 19Analysts Have Made A Financial Statement On ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Yearly Report
Mar 15Should You Investigate ClearPoint Neuro, Inc. (NASDAQ:CLPT) At US$6.18?
Jan 04Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?
Dec 06Is There An Opportunity With ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) 41% Undervaluation?
Nov 06Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?
Aug 18ClearPoint Neuro, Inc. (NASDAQ:CLPT) Looks Just Right With A 40% Price Jump
Apr 17Does ClearPoint Neuro (NASDAQ:CLPT) Have A Healthy Balance Sheet?
Jan 03ClearPoint Neuro: Continuous Great Execution
Sep 19ClearPoint Neuro: Picks & Shovels Galore
Aug 19ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?
Aug 18ClearPoint Neuro: A 'Picks And Shovels' Biotech Company
Jul 25ClearPoint Neuro: Continuous Execution Despite Covid Headwind
May 20Is ClearPoint Neuro (NASDAQ:CLPT) Using Debt In A Risky Way?
Apr 25ClearPoint Neuro: A Strong Recovery Play Once COVID Subsides
Mar 18ClearPoint Neuro (NASDAQ:CLPT) Has Debt But No Earnings; Should You Worry?
Jan 19ClearPoint Neuro: Underlying Growth Potential Concealed By COVID
Jan 14ClearPoint Neuro: Becoming The Neurosurgical Platform Of Choice
Oct 01ClearPoint Neuro: Path To Being The Neurological Navigation Platform Company
Aug 06Health Check: How Prudently Does ClearPoint Neuro (NASDAQ:CLPT) Use Debt?
Jul 19Clearpoint Neuro (CLPT) Investor Presentation - Slideshow
May 28Why We Think Shareholders May Be Considering Bumping Up ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) CEO Compensation
May 27US$35.00 - That's What Analysts Think ClearPoint Neuro, Inc. (NASDAQ:CLPT) Is Worth After These Results
May 13ClearPoint Neuro partners with D&K Engineering
May 10ClearPoint Neuro, Inc.'s (NASDAQ:CLPT) Path To Profitability
Apr 16Revenue & Expenses BreakdownBeta
How ClearPoint Neuro makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 24 | -22 | 24 | 12 |
30 Sep 23 | 22 | -22 | 23 | 12 |
30 Jun 23 | 22 | -21 | 22 | 12 |
31 Mar 23 | 21 | -18 | 21 | 11 |
31 Dec 22 | 21 | -16 | 19 | 11 |
30 Sep 22 | 20 | -16 | 18 | 11 |
30 Jun 22 | 19 | -16 | 18 | 11 |
31 Mar 22 | 17 | -16 | 16 | 11 |
31 Dec 21 | 16 | -14 | 15 | 9 |
30 Sep 21 | 16 | -12 | 14 | 8 |
30 Jun 21 | 15 | -9 | 13 | 7 |
31 Mar 21 | 14 | -7 | 11 | 5 |
31 Dec 20 | 13 | -7 | 11 | 5 |
30 Sep 20 | 12 | -7 | 10 | 4 |
30 Jun 20 | 12 | -6 | 10 | 3 |
31 Mar 20 | 12 | -6 | 10 | 3 |
31 Dec 19 | 11 | -6 | 9 | 3 |
30 Sep 19 | 10 | -5 | 8 | 3 |
30 Jun 19 | 9 | -5 | 8 | 2 |
31 Mar 19 | 8 | -6 | 8 | 2 |
31 Dec 18 | 7 | -6 | 8 | 2 |
30 Sep 18 | 7 | -7 | 8 | 2 |
30 Jun 18 | 7 | -7 | 8 | 2 |
31 Mar 18 | 7 | -7 | 8 | 3 |
31 Dec 17 | 7 | -7 | 8 | 3 |
30 Sep 17 | 7 | -7 | 8 | 3 |
30 Jun 17 | 7 | -8 | 8 | 3 |
31 Mar 17 | 6 | -8 | 8 | 3 |
31 Dec 16 | 6 | -8 | 8 | 3 |
30 Sep 16 | 6 | -8 | 8 | 3 |
30 Jun 16 | 5 | -5 | 8 | 2 |
31 Mar 16 | 5 | -7 | 8 | 2 |
31 Dec 15 | 5 | -8 | 8 | 2 |
30 Sep 15 | 4 | -9 | 9 | 2 |
30 Jun 15 | 3 | -13 | 9 | 3 |
31 Mar 15 | 4 | -11 | 9 | 3 |
31 Dec 14 | 4 | -5 | 8 | 3 |
30 Sep 14 | 4 | -4 | 8 | 3 |
30 Jun 14 | 4 | -4 | 7 | 3 |
31 Mar 14 | 3 | -4 | 7 | 3 |
31 Dec 13 | 4 | -7 | 7 | 3 |
30 Sep 13 | 5 | -4 | 6 | 3 |
30 Jun 13 | 5 | -4 | 6 | 3 |
Quality Earnings: CLPT is currently unprofitable.
Growing Profit Margin: CLPT is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: CLPT is unprofitable, and losses have increased over the past 5 years at a rate of 32% per year.
Accelerating Growth: Unable to compare CLPT's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: CLPT is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (6.3%).
Return on Equity
High ROE: CLPT has a negative Return on Equity (-104.33%), as it is currently unprofitable.